Family CFO Inc - ENDONOVO THERAPEUTICS INC COM ownership

Back to all holdings Add to watchlist

ENDONOVO THERAPEUTICS INC COM's ticker is ENDV and the CUSIP is 29272H300. A total of 1 filers reported holding ENDONOVO THERAPEUTICS INC COM in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
Family CFO Inc ownership history of ENDONOVO THERAPEUTICS INC COM
ValueSharesWeighting
Q3 2023$10.0%600.0%0.00%–
Q2 2023$10.0%600.0%0.00%–
Q1 2023$10.0%600.0%0.00%–
Q4 2022$1–600.0%0.00%–
Q3 2022$0
-100.0%
600.0%0.00%–
Q2 2022$1,000–600.0%0.00%–
Q1 2022$0–600.0%0.00%–
Q4 2021$0–60–0.00%–
 Download
Other shareholders
ENDONOVO THERAPEUTICS INC COM shareholders Q3 2022
NameSharesValueWeighting ↓
Family CFO Inc 60$00.00%
View complete list of ENDONOVO THERAPEUTICS INC COM shareholders